Lynne Ensor, Ph.D., Deputy Directory (Acting), Office of Process and Facilities (OPF), joined FDA in 1998. During her tenure in the FDA’s Center for Drug Evaluation and Research, Lynne worked in the Office of Generic Drugs for 15 years, briefly in the Office of Pharmaceutical Science, and currently serves in Office of Pharmaceutical Quality’s Office of Process Facilities. Prior to being responsible for the oversight of OPF’s process, facility, and microbiology assessment of new, generic, and biologic drug products, Lynne’s responsibilities included supervising the OPF Division of Microbiology Assessment. Dr. Ensor earned her B.S. in Biology and Ph.D. in Microbiology from the University of Maryland, College Park. In addition to Dr. Ensor’s regulatory experience at FDA, Lynne served as a clinical medical technologist at Roche Biomedical Laboratories, a post-doctoral research fellow at the University of Maryland at Baltimore’s School of Medicine, and a script consultant for the Discovery Channel.